Key Discovery Points: Be a Team Player When It Comes to Production
Compliance Tip of the Day: Enhancing Compliance Team Effectiveness
Law Firm ILN-telligence Podcast | Episode 71: Sven Burchartz, Kalus Kenny Intelex
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 151: Erin Ford, EVP & COO, and David Stefanich, Board Chair, SCBIO
The Chat Effect: Improving eDiscovery Workflows for Modern Collaboration Data
Everything Dynamic Everywhere: Managing a More Collaborative Microsoft 365
State AG Pulse | State AGs and Feds: The Dynamics of Influence & Collaboration
PODCAST: Williams Mullen's Trending Now: An IP Podcast - Paralegal Insights: A Collaborative Trademark Practice, Series 3
Stoel Rives | Deeply Rooted Podcast Episode Two: A Bright Future for Agriculture with Phil Ward, CEO of Oregon Future Farmers of America
Strategic Restructuring for the Future, Succeeding in Value-Based Care: How Hospices Can Collaborate Through Network Models
Efficiently and Defensibly Addressing Microsoft Teams Data
M365 in 5 – Part 7: Teams Audio/Video (A/V) Conferencing
M365 in 5 – Part 6: Teams Channels – The virtual collaboration workspace
M365 in 5 – Part 5: Teams Chats – Modern communications
M365 in 5 – Part 4: Teams – An introduction to collaboration
M365 in 5 – Part 2: SharePoint Online – The new file-share environment
Tackling Modern Attachment and Link Challenges in G-Suite, Slack, and Teams
Sitting with the C-Suite: Breaking Boundaries on the Traditional War Room
Sitting with the C-Suite: Creative Problem Solving with Legal Technology
JONES DAY PRESENTS®: Effective Collaboration in Trade Secret Litigation
In the midst of shifting political headwinds and a tight funding market, many life sciences companies are considering their M&A exit. Potential acquirers (both strategic and private equity) have plenty of dry powder and are...more
In I-Mab Biopharma v. Inhibrx, Inc., a trade secret misappropriation case, a federal jury in Delaware sided with the defendants, Inhibrx and its co-founder Brendan Eckelman, on all counts. The jury found no existence of a...more
When two parties come together to discuss a new idea or potential collaboration, the parties are usually operating under the protection of a non-disclosure agreement (NDA). If the parties decide to work together, they will...more
Biotechnology companies in the healthcare/pharmaceutical realm are in an exceptionally competitive field, with many companies competing against each other for a chance to market similar innovative therapeutics. These...more
Protecting your intellectual property is a challenge, especially when entering into a joint development agreement, or “JDA”. When two or more organizations want to work together to develop or enhance their products, combine...more